Metabolic reprogramming and mitochondrial dysfunction in HepG2 cells as potential drivers of AIP pathophysiology

2021 ◽  
Vol 53 ◽  
pp. S19
Author(s):  
M. Longo ◽  
M. Meroni ◽  
E. Paolini ◽  
M.D. Cappellini ◽  
I. Motta ◽  
...  
2017 ◽  
Vol 61 (12) ◽  
pp. 1700440 ◽  
Author(s):  
Yashi Mi ◽  
Guoyuan Qi ◽  
Yuqi Gao ◽  
Runnan Li ◽  
Yiwen Wang ◽  
...  

2019 ◽  
Vol 20 (16) ◽  
pp. 4054 ◽  
Author(s):  
Michael Rogowski ◽  
Lorenza Bellusci ◽  
Martina Sabatini ◽  
Simona Rapposelli ◽  
Shaikh M. Rahman ◽  
...  

3-Iodothyronamine (T1AM) and its synthetic analog SG-2 are rapidly emerging as promising drivers of cellular metabolic reprogramming. Our recent research indicates that in obese mice a sub-chronic low dose T1AM treatment increased lipolysis, associated with significant weight loss independent of food consumption. The specific cellular mechanism of T1AM’s lipolytic effect and its site of action remains unknown. First, to study the mechanism used by T1AM to gain entry into cells, we synthesized a fluoro-labeled version of T1AM (FL-T1AM) by conjugating it to rhodamine (TRITC) and analyzed its cellular uptake and localization in 3T3-L1 mouse adipocytes. Cell imaging using confocal microscopy revealed a rapid intercellular uptake of FL-T1AM into mitochondria without localization to the lipid droplet or nucleus of mature adipocytes. Treatment of 3T3-L1 adipocytes with T1AM and SG-2 resulted in decreased lipid accumulation, the latter showing a significantly higher potency than T1AM (10 µM vs. 20 µM, respectively). We further examined the effects of T1AM and SG-2 on liver HepG2 cells. A significant decrease in lipid accumulation was observed in HepG2 cells treated with T1AM or SG-2, due to increased lipolytic activity. This was confirmed by accumulation of glycerol in the culture media and through activation of the AMPK/ACC signaling pathways.


Biochimie ◽  
2014 ◽  
Vol 106 ◽  
pp. 157-166 ◽  
Author(s):  
Jihane Laafi ◽  
Chadi Homedan ◽  
Caroline Jacques ◽  
Naig Gueguen ◽  
Caroline Schmitt ◽  
...  

Nutrients ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 1979 ◽  
Author(s):  
Arwa Alnahdi ◽  
Annie John ◽  
Haider Raza

Hyperglycemia and hyperlipidemia are the hallmarks of diabetes and obesity. Experimental and epidemiological studies have suggested that dietary management and caloric restriction are beneficial in reducing the complications of diabesity. Studies have suggested that increased availability of energy metabolites like glucose and saturated fatty acids induces metabolic, oxidative, and mitochondrial stress, accompanied by inflammation that may lead to chronic complications in diabetes. In the present study, we used human hepatoma HepG2 cells to investigate the effects of high glucose (25 mM) and high palmitic acid (up to 0.3 mM) on metabolic-, inflammatory-, and redox-stress-associated alterations in these cells. Our results showed increased lipid, protein, and DNA damage, leading to caspase-dependent apoptosis and mitochondrial dysfunction. Glucolipotoxicity increased ROS production and redox stress appeared to alter mitochondrial membrane potential and bioenergetics. Our results also demonstrate the enhanced ability of cytochrome P450s-dependent drug metabolism and antioxidant adaptation in HepG2 cells treated with palmitic acid, which was further augmented with high glucose. Altered NF-kB/AMPK/mTOR-dependent cell signaling and inflammatory (IL6/TNF-α) responses were also observed. Our results suggest that the presence of high-energy metabolites enhances apoptosis while suppressing autophagy by inducing inflammatory and oxidative stress responses that may be responsible for alterations in cell signaling and metabolism.


2019 ◽  
Vol 47 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Van-Tinh Nguyen ◽  
Seok-Chun Ko ◽  
Gun-Woo Oh ◽  
Seong-Yeong Heo ◽  
Won-Kyo Jung

Sign in / Sign up

Export Citation Format

Share Document